CN1980688A - 使肿瘤细胞致死的人α－乳清蛋白(HAMLET)在治疗病毒感染中的应用 - Google Patents

使肿瘤细胞致死的人α－乳清蛋白(HAMLET)在治疗病毒感染中的应用 Download PDF

Info

Publication number
CN1980688A
CN1980688A CNA2005800192369A CN200580019236A CN1980688A CN 1980688 A CN1980688 A CN 1980688A CN A2005800192369 A CNA2005800192369 A CN A2005800192369A CN 200580019236 A CN200580019236 A CN 200580019236A CN 1980688 A CN1980688 A CN 1980688A
Authority
CN
China
Prior art keywords
lactalbumin
alpha
biologically active
virus
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800192369A
Other languages
English (en)
Chinese (zh)
Inventor
C·斯范博格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamlet Pharma AB
Original Assignee
Hamlet Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamlet Pharma AB filed Critical Hamlet Pharma AB
Publication of CN1980688A publication Critical patent/CN1980688A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2005800192369A 2004-04-20 2005-04-20 使肿瘤细胞致死的人α－乳清蛋白(HAMLET)在治疗病毒感染中的应用 Pending CN1980688A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0408752.4 2004-04-20
GBGB0408752.4A GB0408752D0 (en) 2004-04-20 2004-04-20 Therapeutic treatment

Publications (1)

Publication Number Publication Date
CN1980688A true CN1980688A (zh) 2007-06-13

Family

ID=32344046

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800192369A Pending CN1980688A (zh) 2004-04-20 2005-04-20 使肿瘤细胞致死的人α－乳清蛋白(HAMLET)在治疗病毒感染中的应用

Country Status (6)

Country Link
US (1) US20070232550A1 (enExample)
EP (1) EP1765383A1 (enExample)
JP (1) JP2007533728A (enExample)
CN (1) CN1980688A (enExample)
GB (1) GB0408752D0 (enExample)
WO (1) WO2005102382A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途
CN115245562A (zh) * 2021-08-31 2022-10-28 合生元（广州）健康产品有限公司 用于抑制冠状病毒的组合物及其应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113827707B (zh) * 2021-09-30 2023-12-05 北京大学 a-乳白蛋白在抑制冠状病毒中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途
CN115245562A (zh) * 2021-08-31 2022-10-28 合生元（广州）健康产品有限公司 用于抑制冠状病毒的组合物及其应用

Also Published As

Publication number Publication date
JP2007533728A (ja) 2007-11-22
US20070232550A1 (en) 2007-10-04
EP1765383A1 (en) 2007-03-28
GB0408752D0 (en) 2004-05-26
WO2005102382A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
US20080275120A1 (en) Leucine rich composition
RU2012136221A (ru) Доставка активных веществ
Steinbacher et al. Mandibular advancement by distraction osteogenesis for tracheostomy-dependent children with severe micrognathia
HUE031750T2 (en) A method of administering a pulmonary surfactant
CA2817787C (en) Composition comprising a peptide and an inhibitor of viral neuraminidase
WO2001068125A2 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
JP2020502056A5 (enExample)
AU2005268755B2 (en) Composition comprising a pulmonary surfactant and a TNF-derived peptide
CN1980688A (zh) 使肿瘤细胞致死的人α－乳清蛋白(HAMLET)在治疗病毒感染中的应用
BR112019026336A2 (pt) forma de sal de cloridrato de um peptídeo análogo da porção c-terminal de c5a e o uso da mesma, composição, método para induzir uma resposta imune contra uma infecção ou câncer, kit e composto para aumentar uma resposta imune para um agente imunogênico
TWI299993B (en) Aqueous inhalation pharmaceutical composition
ES2532089T3 (es) GH e IGF-1 para el tratamiento de trastornos del crecimiento
Lee Growth factors in oral and maxillofacial surgery: potentials and challenges
CN108135874B (zh) 用于治疗经历了选择性关节置换术的患者的疼痛的组合物
JP4541642B2 (ja) 肺感染症および肺腫瘍を治療するためのリポペプチド類およびリポプロテイン類の使用
WO2021004549A1 (zh) 双靶点血管抑制剂在制备预防或治疗纤维化药物中的用途
JP2007533728A5 (enExample)
WO1996032960A1 (fr) Medicament preventif ou therapeutique, ou les deux, pour les affections ischemiques
CN101711795A (zh) 一种兽用解热抗病毒药物组合物
JPWO1996032960A1 (ja) 虚血性疾患の予防及び／又は治療剤
US20230257446A1 (en) Polypeptides having improved properties
ES2291274T3 (es) Composiciones de t3 estable y metodos de uso de las mismas.
WO2021206548A1 (en) Antimicrobial peptide for treatment and controlling virus infections
Strohmaier et al. Surfactant treatment in the ICU: alternative interpretations of existing evidence

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: CATANIA HAMLET MEDICINE CO., LTD.

Free format text: FORMER OWNER: HAMLET MEDICINE CO., LTD.

Effective date: 20080411

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20080411

Address after: Copenhagen

Applicant after: Hamlet Pharma AB

Address before: Longde, Sweden

Applicant before: Hamlet Pharma AB

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication